Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant.

Dosing cefepime for renal function does not completely prevent neurotoxicity in a kidney transplant patient. Cefepime neurotoxicity has been reported primarily among patients with renal insufficiency who received standard doses of the antibiotic. We report a case of nonconvulsive status epilepticus from dose-adjusted cefepime in a kidney transplant patient.

Acute bacterial arthritis: how long should you wait for culture results?

Background: The optimal incubation period for synovial fluid cultures is unknown.

Objectives: Our study was designed to determine the positivity rate and time to positivity of synovial fluid cultures from adults with suspected acute bacterial arthritis.

Methods: We reviewed the charts of 94 adults who had acute monoarthritis.

Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.

Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency are not represented in clinical trials for heart failure. Moreover, many of the recommended medications can cause haemolysis in this group of patients. We present the case of a 71-year-old woman with G6PD deficiency admitted for acute non-ischemic heart failure with reduced ejection fraction.